NEUROGENETIC PHARMACEUTICALS INC has a total of 15 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Australia and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are SUMMIT OXFORD LTD, CHEMGENEX THERAPEUTICS INC and ST IP HOLDING AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Australia | 2 | |
#3 | Israel | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Japan | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Kounnas Maria Z | 8 |
#2 | Barksdale Nathan S | 6 |
#3 | Knox Bryan M | 6 |
#4 | Comer William T | 6 |
#5 | Pleynet David | 4 |
#6 | Mao Long | 4 |
#7 | Balow Guity P | 4 |
#8 | Comer Daniel D | 4 |
#9 | Cheng Soan | 4 |
#10 | Stauderman Kenneth A | 2 |
Publication | Filing date | Title |
---|---|---|
US2015045353A1 | Formulations containing gamma secretase modulators, methods for preparation and delivery thereof | |
WO2011057214A2 | Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor | |
AU2004247013A1 | Compounds and uses thereof in modulating amyloid beta |